KMB vs. PG: Which Consumer Staples Stock Offers Better Upside Now?
ZACKS·2025-12-19 17:26

Core Insights - Procter & Gamble (PG) and Kimberly-Clark (KMB) are leading companies in the global consumer staples sector, focusing on personal care, household, and hygiene products [1] - PG has a market capitalization of approximately $350 billion, while KMB's market cap is about $45 billion, with PG leveraging its brand equity and supply chain for competitive advantage [2][3] - Both companies face challenges from pressured household budgets and cautious consumer behavior, raising questions about their respective growth strategies [4] Procter & Gamble (PG) - PG has achieved over 40 consecutive quarters of organic sales growth, supported by its focus on non-discretionary categories like fabric care and baby care [12] - The company invests around $10 billion annually in advertising and R&D, which is about 11% of its sales, to drive innovation across key product lines [13] - In the first quarter of fiscal 2026, PG reported adjusted free cash flow productivity of 102%, returning $3.8 billion to shareholders through dividends and share repurchases [14] - Despite stable demand, PG's organic sales growth has slowed to around 2%, with competitive pressures leading to a 30-basis-point decline in global market share [15] - The core gross margin decreased by approximately 50 basis points year-over-year in the fiscal first quarter due to increased investments in brand support and competitive spending [16] - The Zacks Consensus Estimate for PG indicates year-over-year increases of 3.1% in sales and 2.6% in EPS for the current fiscal year [20] Kimberly-Clark (KMB) - KMB is focusing on a multi-year transformation strategy aimed at volume-plus-mix growth, emphasizing innovation and productivity to enhance competitiveness [3][5] - The 2024 Transformation Initiative aims to create a more agile operating structure, including portfolio simplification and productivity improvements [6] - KMB's acquisition of Kenvue is expected to create a $32 billion health and wellness leader, with anticipated synergies of $2.1 billion [8] - The company faces near-term challenges from softer global demand and increased promotional activity, impacting profitability and leading to a decline in adjusted gross margin [9] - The Zacks Consensus Estimate for KMB suggests year-over-year declines of 17.8% in sales and 16.4% in EPS for the current financial year [17] - KMB is trading at a forward price-to-sales (P/S) multiple of 1.99, below its three-year median of 2.21 [22] Comparative Analysis - PG is viewed as better positioned for near to medium-term performance due to its stable earnings visibility and defensive business mix, while KMB's recovery relies on successful execution of its transformation strategy [26] - Both companies currently hold a Zacks Rank of 3 (Hold), indicating a neutral outlook [27]